Cure8 trial brief
Self-management programs that teach cognitive behavioral strategies, symptom tracking, relaxation, sleep and diet skills could help people with IBD manage symptoms and day-to-day quality of life without relying solely on medications or procedures.
This trial tests whether an online, nurse-supported 8-week program is feasible and acceptable for adults with Crohn’s disease or ulcerative colitis.
Adult patients with Crohn’s disease or ulcerative colitis who are experiencing symptoms, caregivers, clinicians interested in behavioral and self-management interventions, and researchers studying nonpharmacologic IBD therapies.
The study enrolled adults (18–75) with a healthcare diagnosis of IBD who reported current symptoms and could read/write English. Participants at the University of Washington were randomized to the 8-week online CSM intervention plus brief weekly phone check-ins with a registered nurse, or to usual care without the program.
The trial’s primary focus was feasibility and acceptability (recruitment and intervention feasibility measured with the Feasibility of Intervention Measure). Planned enrollment was 55 and the registry lists the study as completed.
This record describes the study design and planned outcomes; it does not report trial results or effectiveness data in the registry entry. Practical note: If you’re interested in nonpharmacologic approaches to living with IBD (CBT, relaxation, diet, sleep hygiene, symptom tracking), this trial’s intervention is directly relevant.
To know whether the program improved symptoms or quality of life, look for a linked publication or contact the study team at the University of Washington.
This entry is a clinicaltrials.gov trial record (study NCT05651542) summarizing the study design and planned outcomes; the registry entry does not provide trial results. The study focused on feasibility and acceptability rather than definitive efficacy outcomes.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The trial could show whether a smart-label app plus clinician alerts improves medication adherence and downstream clinical outcomes for people with Crohn's disease or ulcerative colitis starting oral or subcutaneous...
Sleep timing and morning light are modifiable, nonpharmacologic factors that could influence IBD quality of life and symptoms. If effective, a simple at-home light therapy could be an accessible adjunct to usual care.
Chronic pain is common in people with Crohn’s disease and ulcerative colitis and can persist despite controlling gut inflammation. Brief online pain-education programs could offer a low-burden, scalable way to reduce...
